Peptide CDMO Services

Peptide development continues to evolve as programs advance toward more complex sequences, higher purity requirements, and accelerated regulatory timelines. This flyer highlights how modern peptide manufacturing leverages a diverse toolbox — spanning solid‑phase, liquid‑phase, chemo‑enzymatic, and bio‑based synthesis—to improve efficiency across scales ranging from early feasibility to commercial‑ready volumes. Analytical innovation plays a central role, with specialized methods for stereochemical control, impurity tracking, and prediction tools that assess solubility, hydrophobicity, and aggregation risk early in development.

Process‑intensified approaches, including flow‑enabled liquid‑phase synthesis, continuous deprotection, nanofiltration, and hydrogenation, help overcome epimerization, reduce solvent consumption, and streamline purification. The flyer also outlines downstream capabilities such as lyophilization curve development, tangential‑flow filtration, spray‑drying optimization, and controlled precipitation — each aimed at strengthening stability, scalability, and manufacturability.

Teams navigating IND and NDA milestones will find practical guidance on impurity management, platform selection, and scale‑up considerations that support faster, more predictable advancement. Explore the full flyer to see how these capabilities shape a modern approach to peptide development.